Find a Tender
complete
Official procurement procedure
NHS National Pharmaceuticals Transition 2021_3
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published7
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS National Pharmaceuticals Transition 2021_3". Published status: complete. Published value: Value not published. 7 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The NHS Commissioning Board (operating under the name of NHS England) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
46Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England) | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published4 Nov 2021, 14:00 GMT | Last source update4 Nov 2021, 14:00 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02b7a6 | ||
What is being bought
NHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633
What changed
From the official release history
- tender value changed
4 Nov 2021, 14:00 GMT - Status changed to complete
4 Nov 2021, 14:00 GMT - Official notice release published
4 Nov 2021, 14:00 GMT - Submission deadline changed to published date
4 Nov 2021, 14:00 GMT - Published value updated to £214,113,004
2 Jun 2021, 16:02 BST - Status changed to active
2 Jun 2021, 16:02 BST - Official notice release published
2 Jun 2021, 16:02 BST - Submission deadline changed to 7 Jul 2021, 13:00 BST
2 Jun 2021, 16:02 BST - Buyer information updated
2 Jun 2021, 16:02 BST
Lots and requirements (7)
Published by the contracting authority
- Lot 1 · #1Hospital Only Products – CESW regioncancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products:LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition:LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Hospital Only Products – LSNE regioncancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Hospital Only Products – NWLN regioncancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4Oral (plus non-parenteral) products: All regionscancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #5Transition Products – CESW regioncancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #6Transition Products – LSNE regioncancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #7Transition Products – NWLN regioncancelledPublished valueNot publishedNHS National Pharmaceuticals Transition 2021_3Offer reference number: CM/PHG/21/5633Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 01/10/2021 to 31/05/2024 (32 months)Hospital Only Products: LSNE: 01/10/2021 to 30/06/2022 (9 months)NWLN:01/10/2021 to 31/01/2023 (16 months)CESW:01/10/2021 to 30/09/2023 (24 months)Transition: LSNE: 26/10/2021 to 30/06/2022 (8 months)NWLN: 26/10/2021 to 31/01/2023 (15 months)CESW: 26/10/2021 to 30/09/2023 (23 months)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
4 Nov 2021, 14:00 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1 - Contract active
Signed 14 Sept 2021, 00:00 BST · £1
Commercial outcome and competition
Awards Glenmark Pharmaceuticals Europe Limited Not published · Not published · active Torbay Pharmaceuticals Not published · Not published · active Ranbaxy UK Not published · Not published · active Aspire Pharma Limited Not published · Not published · active Kent Pharma Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Panpharma UK Limited Not published · Not published · active Teva UK Limited Not published · Not published · active Drugsrus Ltd Not published · Not published · active Alturix Not published · Not published · active Colonis Pharma Ltd Not published · Not published · active Zentiva Pharma UK Ltd Not published · Not published · active Ambe Medical Group Ltd Not published · Not published · active Aspen Pharmacare UK Limited Not published · Not published · active CST Pharma Limited Not published · Not published · active Macure Pharma ApS Not published · Not published · active Accord-UK Ltd Not published · Not published · active Lucane Pharma Not published · Not published · active Mercury Pharmaceuticals Limited Not published · Not published · active Wockhardt UK Limited Not published · Not published · active Aguettant Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Teva UK Limited Not published · Not published · active Drugsrus Ltd Not published · Not published · active Colonis Pharma Ltd Not published · Not published · active Macure Pharma ApS Not published · Not published · active Accord-UK Ltd Not published · Not published · active Seacross Pharmaceuticals Ltd Not published · Not published · active Laboratorio Reig Jofre SA Not published · Not published · active Consilient Health Ltd Not published · Not published · active Drugsrus Ltd Not published · Not published · active Alturix Not published · Not published · active Brown and Burk UK Ltd Not published · Not published · active Colonis Pharma Ltd Not published · Not published · active Macure Pharma ApS Not published · Not published · active Glenmark Pharmaceuticals Europe Limited Not published · Not published · active Day Lewis Medical Ltd Not published · Not published · active Napp Pharmaceuticals Ltd Not published · Not published · active Cipla (EU) Ltd Not published · Not published · active Mylan Not published · Not published · active Teva UK Limited Not published · Not published · active Amarox Limited Not published · Not published · active Teva UK Limited Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Cipla (EU) Ltd Not published · Not published · active Mylan Not published · Not published · active Amarox Limited Not published · Not published · active Teva UK Limited Not published · Not published · active Accord-UK Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active Cipla (EU) Ltd Not published · Not published · active Amarox Limited Not published · Not published · active Teva UK Limited Not published · Not published · active medac Pharma LLP Not published · Not published · active Kensington Pharma Ltd Not published · Not published · active Mylan Not published · Not published · active Morningside Pharmaeuticals Not published · Not published · active |
Contracts Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Oral (plus non-parenteral) products: All regions £1 · signed 14 Sept 2021, 00:00 BST · active Oral (plus non-parenteral) products: All regions £1 · signed 14 Sept 2021, 00:00 BST · active Oral (plus non-parenteral) products: All regions £1 · signed 14 Sept 2021, 00:00 BST · active Oral (plus non-parenteral) products: All regions £1 · signed 14 Sept 2021, 00:00 BST · active Oral (plus non-parenteral) products: All regions £1 · signed 14 Sept 2021, 00:00 BST · active Oral (plus non-parenteral) products: All regions £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – LSNE region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Transition Products – NWLN region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active Hospital Only Products – CESW region £1 · signed 14 Sept 2021, 00:00 BST · active |
Bid statistics bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) bids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) electronicBids: 58 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromEU: 5 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) foreignBidsFromNonEU: 53 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) smeBids: 30 (lot 1) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) bids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) electronicBids: 58 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromEU: 5 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) foreignBidsFromNonEU: 53 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) smeBids: 30 (lot 2) bids: 58 (lot 3) bids: 58 (lot 3) bids: 58 (lot 3) bids: 58 (lot 3) bids: 58 (lot 3) bids: 58 (lot 3) bids: 58 (lot 3) electronicBids: 58 (lot 3) electronicBids: 58 (lot 3) electronicBids: 58 (lot 3) electronicBids: 58 (lot 3) electronicBids: 58 (lot 3) electronicBids: 58 (lot 3) electronicBids: 58 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromEU: 5 (lot 3) foreignBidsFromNonEU: 53 (lot 3) foreignBidsFromNonEU: 53 (lot 3) foreignBidsFromNonEU: 53 (lot 3) foreignBidsFromNonEU: 53 (lot 3) foreignBidsFromNonEU: 53 (lot 3) foreignBidsFromNonEU: 53 (lot 3) foreignBidsFromNonEU: 53 (lot 3) smeBids: 30 (lot 3) smeBids: 30 (lot 3) smeBids: 30 (lot 3) smeBids: 30 (lot 3) smeBids: 30 (lot 3) smeBids: 30 (lot 3) smeBids: 30 (lot 3) bids: 15 (lot 4) bids: 15 (lot 4) bids: 15 (lot 4) bids: 15 (lot 4) bids: 15 (lot 4) bids: 15 (lot 4) electronicBids: 15 (lot 4) electronicBids: 15 (lot 4) electronicBids: 15 (lot 4) electronicBids: 15 (lot 4) electronicBids: 15 (lot 4) electronicBids: 15 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromEU: 0 (lot 4) foreignBidsFromNonEU: 15 (lot 4) foreignBidsFromNonEU: 15 (lot 4) foreignBidsFromNonEU: 15 (lot 4) foreignBidsFromNonEU: 15 (lot 4) foreignBidsFromNonEU: 15 (lot 4) foreignBidsFromNonEU: 15 (lot 4) smeBids: 10 (lot 4) smeBids: 10 (lot 4) smeBids: 10 (lot 4) smeBids: 10 (lot 4) smeBids: 10 (lot 4) smeBids: 10 (lot 4) bids: 16 (lot 5) bids: 16 (lot 5) bids: 16 (lot 5) bids: 16 (lot 5) bids: 16 (lot 5) bids: 16 (lot 5) electronicBids: 16 (lot 5) electronicBids: 16 (lot 5) electronicBids: 16 (lot 5) electronicBids: 16 (lot 5) electronicBids: 16 (lot 5) electronicBids: 16 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromNonEU: 16 (lot 5) foreignBidsFromNonEU: 16 (lot 5) foreignBidsFromNonEU: 16 (lot 5) foreignBidsFromNonEU: 16 (lot 5) foreignBidsFromNonEU: 16 (lot 5) foreignBidsFromNonEU: 16 (lot 5) smeBids: 6 (lot 5) smeBids: 6 (lot 5) smeBids: 6 (lot 5) smeBids: 6 (lot 5) smeBids: 6 (lot 5) smeBids: 6 (lot 5) bids: 16 (lot 6) bids: 16 (lot 6) electronicBids: 16 (lot 6) electronicBids: 16 (lot 6) foreignBidsFromEU: 0 (lot 6) foreignBidsFromEU: 0 (lot 6) foreignBidsFromNonEU: 16 (lot 6) foreignBidsFromNonEU: 16 (lot 6) smeBids: 10 (lot 6) smeBids: 10 (lot 6) bids: 16 (lot 7) bids: 16 (lot 7) bids: 16 (lot 7) bids: 16 (lot 7) electronicBids: 16 (lot 7) electronicBids: 16 (lot 7) electronicBids: 16 (lot 7) electronicBids: 16 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromNonEU: 16 (lot 7) foreignBidsFromNonEU: 16 (lot 7) foreignBidsFromNonEU: 16 (lot 7) foreignBidsFromNonEU: 16 (lot 7) smeBids: 10 (lot 7) smeBids: 10 (lot 7) smeBids: 10 (lot 7) smeBids: 10 (lot 7) |
Buyer and organisations in this procedure
The NHS Commissioning Board (operating under the name of NHS England)
Contracting authority GB-FTS-2505Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published